chevron_leftBack
As of 18 June 2026, Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. has a market cap of $373.12M USD, ranking #17205 globally and #5362 in China.
It ranks #1562 in the Healthcare sector, and #562 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$373.12MUSD
2.52B CNY
Enterprise Value
$384.49MUSD
2.6B CNY
Revenue (TTM)
$68.48MUSD
462.78M CNY
EBITDA (TTM)
$4.79MUSD
32.37M CNY
Net Income (TTM)
-$35.32MUSD
-238.72M CNY
EBITDA Margin
7%
Profit Margin
-52%
PS Ratio
5.4
PB Ratio
1.9
EV/EBITDA
67.2
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Hong Li Lin
open_in_new
Employees
1,328
Founded
2000
Website
zjspas.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 0% | 5.3% | -3.2% | -11% | -17% | 3.5% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
603168
浙江莎普爱思药业股份有限公司 Class A
ISIN: CNE100001TG0
Shares Out.:
Shares Outstanding:
372.515M1
Shares Float:
284.696M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
6.74 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.99B
14K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.77B
13K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
8K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
5K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.56B
4K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
4K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
204K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
147K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
97K%
|
97.4
|
|
SIX: RO
|
$321.45B
86K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.52B
77K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.59B
73K%
218.9B CHF
|
20.5
|
chevron_leftBack